Clinical Trials
2 trialsNCT04975555 2026-06-03
Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy
University of Alabama at Birmingham
Phase 2 Completed
NCT06377059 2026-05-15
Early Detection of Complications During Immunotherapy for Haematological Malignancy
Rigshospitalet, Denmark
Phase NA Recruiting